Long Term Safety And Efficacy Study Of Pregabalin (Lyrica) In Subjects With Generalized Anxiety Disorder [ESTUDIO DE SEGURIDAD Y EFICACIA A LARGO PLAZO DE PREGABALINA EN SUJETOS CON TRASTORNO DE ANSIEDAD GENERALIZADA]
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2013
At a glance
- Drugs Pregabalin (Primary) ; Lorazepam
- Indications Generalised anxiety disorder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 11 Aug 2012 Planned number of patients changed from 600 to 794 as reported by European Clinical Trials Database.
- 09 Apr 2012 Actual patient number changed from 600 to 621 as reported by ClinicalTrials.gov
- 09 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.